Home » Topics » BioWorld Science

BioWorld Science
RSS

Update from large animal pilot dosing study of BB-301 for oculopharyngeal muscular dystrophy

Sep. 9, 2021

ProQR and Lilly to use Axiomer RNA editing platform to target liver and nervous system disorders

Sep. 9, 2021

NIH develops PET radioligands targeting CSF-1R for neuroinflammation

Sep. 9, 2021

Microglial activation and tau spreading correlate with Braak stages in AD

Sep. 9, 2021

New DNA vaccine shows promise against Ebola virus infection

Sep. 9, 2021

New EGFR mutant inhibitors identified at Betta Pharmaceuticals

Sep. 9, 2021

Amgen describes new PRMT5 inhibitors

Sep. 9, 2021

New IRAK-4/FLT-3 inhibitors identified at PharmaBlock Sciences

Sep. 9, 2021

Genfleet Therapeutics discovers RIP-1 inhibitors

Sep. 9, 2021

GABA-A alpha5 PAM RO-7015738 presented for neurological disorders

Sep. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...